News Tag: 2023 newsletters

The “High Five Trial” for High-Risk Prostate Cancer Activates (NRG-GU013)

Read More

NRG PCOR Educational Session at #NRG2024 in Orlando

Read More

Honoring a Legacy: Dr. Worta McCaskill-Stevens

Read More

NRG-BR008, HERO Study Seeks to Optimize use of Radiotherapy in Patients with Early-Stage, Low Risk, HER2-Positive Breast Cancer

Read More

ADVERSE EVENT REPORTING: One site’s use of EMR functionality to establish Best Practice

Read More

FORTE Study Update – November 2023

Read More

New Vice Chair named for NRG Health Disparities Committee (HDC)

Read More

FORTE Study Update – October 2023

Read More

Informed Consent Guidance Now Available

Read More